Source: Home K-line original Jin Wenyu At the beginning of 2023, when communicating with investors, Martian (300894.SZ) set a growth target for the next three years: from 2023 to 2025, revenue will be no less than 2.9 billion yuan, 35 billion, 4.2 billion yuan, and net profit shall not be less than 450 million yuan, 550 million yuan, or 680 million yuan.
But in the first year, the Martians failed to achieve the goals they set.
According to its just-released annual report data, Martian will achieve operating income of 2.139 billion yuan in 2023, a year-on-year decrease of 6.03%; it will achieve a net profit attributable to shareholders of listed companies of 247 million yuan, a year-on-year decrease of 21.39%.
Neither revenue nor net profit reached the target value.
In fact, Martian has experienced a decline in both revenue and net profit for two consecutive years.
Its revenue and net profit have already declined by 1.81% and 16.29% respectively in 2022, and the decline will be even greater in 2023.
Leju Finance has noticed that among the factors that affect net profits, the provision for bad debts of trust products is an important factor.
According to the annual report, on March 2, 2023, Martian used its own funds of 50 million yuan to subscribe for the Longsheng No. 1 trust product, with an expiration date of December 2, 2023.
However, as of March 31, 2024, the company has not received the principal and investment income of the above-mentioned trust products.
It is understood that the full name of the product of Martian Stepping on Thunder is \”Zhongrong Trust Longsheng No. 1 Collective Fund Trust Plan\”, which was established on July 16, 2012 and is sold by Zhongzhi Wealth Company Hengtian Wealth.
If Zhongrong Trust does not stop payment, the trust plan will continue to be issued.
Through the company\’s continuous tracking of the invested products and market public opinion, Martians are concerned that the underlying products invested in the above-mentioned trust financial products may face the risk of being unable to be redeemed, so the above-mentioned trust financial products may face the risk of being unable to be redeemed.
Leju Finance has learned that Martians are not the only A-share companies that have stepped on the products of Lei Zhongrong Trust.
Since 2023, many companies such as Anji Food, Fashilong, Anxu Biotechnology, Changguang Huaxin, and Jinfang Energy have issued announcements stating that the Zhongrong Trust products they purchased have been overdue.
For example, at the beginning of 2023, Changguang Huaxin (688048.SH) and Jinfang Energy (001201.SH) announced that the former subscribed for Zhongrong-Longsheng No. 1 for 60 million yuan, and the latter subscribed for Zhongrong-Longsheng No. 1 for 40 million yuan. Yuanrong No. 1 is overdue and has not yet been paid, so there is a risk that the principal and interest will not be fully recovered.
In October last year, Anxu Biotech (688075.SH) also issued a risk warning announcement regarding overdue redemption of some Zhongrong trust products purchased by the company, saying that the company used 100 million yuan of idle own funds to purchase Zhongrong International in September 2022. Longsheng No. 1 trust product under the trust, but the principal and investment income of this trust plan have not been received overdue.
At present, Martians have taken various measures to safeguard their rights, including sending a communication letter to Zhongrong Trust, reporting Zhongrong Trust’s illegal activities to the Heilongjiang Financial Supervision and Administration Bureau, and deciding to prosecute.
After comprehensive consideration, the audit agency hired by the Martians, Tianjian Accounting Firm (Special General Partnership), finally accrued 80% of the losses on the trust product, totaling 40 million yuan.
